Axsome Therapeutics announces closing of IPO
Axsome announced the closing of its initial public offering of 5,666,667 shares of its common stock at a public offering price of $9.00 per share. Axsome granted underwriters a 30-day option to purchase up to an aggregate of 850,000 additional shares. Net proceeds was approximately $45.4 million, November 24, 2015